{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:15:58Z","timestamp":1760267758154,"version":"3.40.5"},"reference-count":55,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.4155\/fmc-2021-0058","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T08:29:30Z","timestamp":1619598570000},"page":"1073-1081","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Histamine H\n            <sub>2<\/sub>\n            Receptor Radioligands: Triumphs and Challenges"],"prefix":"10.1080","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-9868","authenticated-orcid":false,"given":"Steffen","family":"Pockes","sequence":"first","affiliation":[{"name":"Institute of Pharmacy, University of Regensburg, Universit\u00e4tsstra\u00dfe 31, Regensburg, D-93053, Germany"},{"name":"Department of Neurology, University of Minnesota, Minneapolis, MN, 55455, USA"},{"name":"Department of Medicinal Chemistry, Institute for Therapeutics Discovery &amp; Development, University of Minnesota, Minneapolis, MN, 55414, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4440-3867","authenticated-orcid":false,"given":"Katharina","family":"Tropmann","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, University of Regensburg, Universit\u00e4tsstra\u00dfe 31, Regensburg, D-93053, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1966.tb01674.x"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/236385a0"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706440"},{"issue":"3","key":"e_1_3_2_6_1","first-page":"435","article-title":"The pharmacology of cimetidine, a new histamine H2-receptor antagonist","volume":"53","author":"Brimblecombe RW","year":"1975","unstructured":"Brimblecombe RW , DuncanWA , DurantGJet al. The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br. J. Pharmacol.53(3), 435\u2013436 (1975).","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"e_1_3_2_7_1","first-page":"464P","article-title":"Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]","volume":"66","author":"Bradshaw J","year":"1979","unstructured":"Bradshaw J , BrittainRT , ClitherowJWet al. Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Br. J. Pharmacol.66(3), 464P (1979).","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"e_1_3_2_8_1","first-page":"49","article-title":"Effect of a new potent H2-blocker, 3-]]] 2-[(diaminomethylene) amino]-4-thiazolyl] methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs","volume":"256","author":"Takagi T","year":"1982","unstructured":"Takagi T , TakedaM , MaenoH. Effect of a new potent H2-blocker, 3-]]] 2-[(diaminomethylene) amino]-4-thiazolyl] methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs. Arch. Int. Pharmacodyn. Ther.256(1), 49 (1982).","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(85)90331-X"},{"issue":"4","key":"e_1_3_2_10_1","first-page":"703","article-title":"Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460)","volume":"35","author":"Tarutani M","year":"1985","unstructured":"Tarutani M , SakumaH , ShiratsuchiK , MiedaM. Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460). Arzneimittelforschung.35(4), 703\u2013706 (1985).","journal-title":"Arzneimittelforschung."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90143-6"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14524"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200800296"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm800841w"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm201128q"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.01.012"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.8b00128"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/open.201900011"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01494"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113190"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11406.x"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.10.30"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.10.022"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2016.08.022"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlcr.3085"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90015-2"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(80)90138-1"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01968040"},{"issue":"3","key":"e_1_3_2_29_1","first-page":"P547","article-title":"Radioligand binding studies using [3H]-cimetidine and [3H]-ranitidine","volume":"72","author":"Bristow DR","year":"1981","unstructured":"Bristow DR , HareJR , HearnJR , MartinLE. Radioligand binding studies using [3H]-cimetidine and [3H]-ranitidine. Br. J. Pharmacol.72(3), P547\u2013P548 (1981).","journal-title":"Br. J. Pharmacol."},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb13157.x"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201402344"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70332-3"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/304065a0"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.60.6.1210"},{"issue":"4","key":"e_1_3_2_35_1","first-page":"569","article-title":"G protein-linked receptors labeled by [3H] histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]","volume":"43","author":"Sinkins WG","year":"1993","unstructured":"Sinkins WG , KandelM , KandelSIet al. G protein-linked receptors labeled by [3H] histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]. Mol. Pharmacol.43(4), 569\u2013582 (1993).","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1991.71.1.1"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964958"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.5.1658"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)91240-H"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-9002(92)90180-C"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.255711"},{"key":"e_1_3_2_42_1","volume-title":"Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H2 Receptor [PhD thesis].","author":"Biselli S","year":"2019","unstructured":"Biselli S . Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H2 Receptor [PhD thesis].University of Regensburg, Germany (2019)."},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498258209052468"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlcr.2580201009"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510080606"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1998.tb02140.x"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528709094480"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.100"},{"issue":"9","key":"e_1_3_2_49_1","first-page":"958","article-title":"Localization of 14C-nizatidine in the gastric wall of rats","volume":"41","author":"Sano H","year":"1991","unstructured":"Sano H , MeraY , AraiKet al. Localization of 14C-nizatidine in the gastric wall of rats. Arzneimittelforschung.41(9), 958\u2013961 (1991).","journal-title":"Arzneimittelforschung."},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198800353-00009"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1163\/156856002321544954"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00398a028"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.010249"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707644"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1254\/fpj.105.231"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(03)00235-X"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11406.x"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc-2021-0058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:50:59Z","timestamp":1716493859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc-2021-0058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.4155\/fmc-2021-0058"],"URL":"https:\/\/doi.org\/10.4155\/fmc-2021-0058","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"type":"print","value":"1756-8919"},{"type":"electronic","value":"1756-8927"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}